NYRADA INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.051 AUD | +2.00% |
|
-8.93% | +131.82% |
| Jun. 26 | Strong Domestic Inflation Data Push Down Australian Shares | MT |
| Jun. 26 | Nyrada Partners with Rebion on Brain Injury Therapy Development | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 5.66M | - | - | - | - | - | |
| 846B | ||||||
| 628B | ||||||
| 360B | - | - | ||||
| 322B | ||||||
| 297B |
- Stock Market
- Equities
- NYR Stock
- Charts Nyrada Inc.
- Sector Chart
